We also observed a significant difference at the early time point in the proliferative CD4+ and CD8+ T-cell responses between post-COVID-19 patients with pneumonia or mild symptoms (but not between either the post-COVID-19 patient group or vaccinated subjects). The gene discussed is CD8A; the disease is susceptibility to pneumonia measurement.